This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ermakova, S. P. Articles by Dong, Z. Search for Related Content PubMed PubMed Citation Articles by Ermakova, S. P. Articles by Dong, Z.

(–)–Epigallocatechin Gallate Overcomes Resistance to Etoposide-Induced Cell Death by Targeting the Molecular Chaperone Glucose-Regulated Protein 78

Hormel Institute, University of Minnesota, Austin, Minnesota

Requests for reprints: Zigang Dong, Hormel Institute, University of Minnesota, 801 16th Avenue Northeast, Austin, MN 55912. Phone: 507-437-9600; Fax: 507-437-9606; E-mail: zgdong{at}hi.umn.edu.

Many beneficial properties have been attributed to (–)–epigallocatechin gallate (EGCG), including chemopreventive, anticarcinogenic, and antioxidant actions. In this study, we investigated the effects of EGCG on the function of glucose-regulated protein 78 (GRP78), which is associated with the multidrug resistance phenotype of many types of cancer cells. Our investigation was directed at elucidating the mechanism of the EGCG and GRP78 interaction and providing evidence about whether EGCG modulates the activity of anticancer drugs through the inhibition of GRP78 function. We found that EGCG directly interacted with GRP78 at the ATP-binding site of protein and regulated its function by competing with ATP binding, resulting in the inhibition of ATPase activity. EGCG binding caused the conversion of GRP78 from its active monomer to the inactive dimer and oligomer forms. Further, we showed that EGCG interfered with the formation of the antiapoptotic GRP78-caspase-7 complex, which resulted in an increased etoposide-induced apoptosis in cancer cells. We also showed that EGCG significantly suppressed the transformed phenotype of breast cancer cells treated with etoposide. Overall, these results strongly suggested that EGCG could prevent the antiapoptotic effect of GRP78, which usually suppresses the caspase-mediated cell death pathways in drug-treated cancer cells, contributing to the development of drug resistance. (Cancer Res 2006; 66(18): 9260-9) (Cancer Res 2006; 66(18): 9260-9)

This article has been cited by other articles:

				D. M. Shin Oral Cancer Prevention Advances with a Translational Trial of Green Tea Cancer Prevention Research, November 1, 2009; 2(11): 919 - 921. [Abstract] [Full Text] [PDF]

				E. B. Golden, P. Y. Lam, A. Kardosh, K. J. Gaffney, E. Cadenas, S. G. Louie, N. A. Petasis, T. C. Chen, and A. H. Schonthal Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors Blood, June 4, 2009; 113(23): 5927 - 5937. [Abstract] [Full Text] [PDF]

				A. M. Bode and Z. Dong Epigallocatechin 3-Gallate and Green Tea Catechins: United They Work, Divided They Fail Cancer Prevention Research, June 1, 2009; 2(6): 514 - 517. [Full Text] [PDF]

				A. M. Bode and Z. Dong Signal Transduction Molecules as Targets for Cancer Prevention Sci. Signal., February 24, 2009; 2(59): mr2 - mr2. [Abstract] [Full Text] [PDF]

				C. C. Jiang, Z. G. Mao, K. A. Avery-Kiejda, M. Wade, P. Hersey, and X. D. Zhang Glucose-regulated protein 78 antagonizes cisplatin and adriamycin in human melanoma cells Carcinogenesis, February 1, 2009; 30(2): 197 - 204. [Abstract] [Full Text] [PDF]

				J. J. Virrey, D. Dong, C. Stiles, J. B. Patterson, L. Pen, M. Ni, A. H. Schonthal, T. C. Chen, F. M. Hofman, and A. S. Lee Stress Chaperone GRP78/BiP Confers Chemoresistance to Tumor-Associated Endothelial Cells Mol. Cancer Res., August 1, 2008; 6(8): 1268 - 1275. [Abstract] [Full Text] [PDF]

				N. J. Kang, K. W. Lee, D. E. Lee, E. A. Rogozin, A. M. Bode, H. J. Lee, and Z. Dong Cocoa Procyanidins Suppress Transformation by Inhibiting Mitogen-activated Protein Kinase Kinase J. Biol. Chem., July 25, 2008; 283(30): 20664 - 20673. [Abstract] [Full Text] [PDF]

				S. Brierley-Hobson Binding of (-)-epigallocatechin-3-gallate to the Hsp70 ATPase domain may promote apoptosis in colorectal cancer Bioscience Horizons, March 1, 2008; 1(1): 9 - 18. [Abstract] [Full Text] [PDF]

				D. Dong, M. Ni, J. Li, S. Xiong, W. Ye, J. J. Virrey, C. Mao, R. Ye, M. Wang, L. Pen, et al. Critical Role of the Stress Chaperone GRP78/BiP in Tumor Proliferation, Survival, and Tumor Angiogenesis in Transgene-Induced Mammary Tumor Development Cancer Res., January 15, 2008; 68(2): 498 - 505. [Abstract] [Full Text] [PDF]

				P. Pyrko, A. H. Schonthal, F. M. Hofman, T. C. Chen, and A. S. Lee The Unfolded Protein Response Regulator GRP78/BiP as a Novel Target for Increasing Chemosensitivity in Malignant Gliomas Cancer Res., October 15, 2007; 67(20): 9809 - 9816. [Abstract] [Full Text] [PDF]

				T. M. B. Nguyen, I. V. Subramanian, A. Kelekar, and S. Ramakrishnan Kringle 5 of human plasminogen, an angiogenesis inhibitor, induces both autophagy and apoptotic death in endothelial cells Blood, June 1, 2007; 109(11): 4793 - 4802. [Abstract] [Full Text] [PDF]

				A. S. Lee GRP78 Induction in Cancer: Therapeutic and Prognostic Implications Cancer Res., April 15, 2007; 67(8): 3496 - 3499. [Abstract] [Full Text] [PDF]

				Y. Fu, J. Li, and A. S. Lee GRP78/BiP Inhibits Endoplasmic Reticulum BIK and Protects Human Breast Cancer Cells against Estrogen Starvation-Induced Apoptosis Cancer Res., April 15, 2007; 67(8): 3734 - 3740. [Abstract] [Full Text] [PDF]